Dydrogesterone
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351607This classification denotes a therapeutic progestin with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90I02KLE8K, chemically known as 9beta,10alpha-pregna-4,6-diene-3,20-dione but generally known as dydrogesterone, which bears US NIH Compound Identifier 9051. European Medicines Agency schedules Dydrogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06433MIG. The term DYDROGESTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules dydrogesterone in its Anatomical Therapeutic Chemical (ATC) Classification. DYDROGESTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dydrogesterone under HS 29372300 and SITC 54153. As of Q4 2014, DYDROGESTERONE remains the US FDA Preferred Term for this commodity. Dydrogesterone bears US NLM identifiers UMLS ID C0013340 and NCI Concept Code C65501. SMILES: O=C(C1C2(C(C3C(CC2)C2(C(=CC(=O)CC2)C=C3)C)CC1)C)C.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.